Your browser is no longer supported. Please, upgrade your browser.
QDEL Quidel Corporation monthly Stock Chart
QDEL [NASD]
Quidel Corporation
Index- P/E76.53 EPS (ttm)3.56 Insider Own8.90% Shs Outstand42.12M Perf Week-3.44%
Market Cap11.97B Forward P/E17.46 EPS next Y15.63 Insider Trans-4.85% Shs Float37.01M Perf Month11.35%
Income154.70M PEG10.63 EPS next Q4.06 Inst Own85.70% Short Float6.22% Perf Quarter71.98%
Sales655.10M P/S18.27 EPS this Y-0.50% Inst Trans-3.77% Short Ratio1.85 Perf Half Y259.15%
Book/sh14.52 P/B18.79 EPS next Y30.30% ROA16.60% Target Price264.75 Perf Year393.33%
Cash/sh1.65 P/C164.90 EPS next 5Y7.20% ROE26.80% 52W Range53.61 - 306.72 Perf YTD263.53%
Dividend- P/FCF78.55 EPS past 5Y59.90% ROI15.20% 52W High-11.07% Beta1.26
Dividend %- Quick Ratio1.10 Sales past 5Y23.80% Gross Margin66.30% 52W Low408.79% ATR15.51
Employees1250 Current Ratio1.60 Sales Q/Q86.30% Oper. Margin29.20% RSI (14)58.45 Volatility6.37% 5.77%
OptionableYes Debt/Eq0.02 EPS Q/Q5226.90% Profit Margin23.60% Rel Volume0.57 Prev Close285.35
ShortableYes LT Debt/Eq0.00 EarningsJul 30 AMC Payout0.00% Avg Volume1.24M Price272.76
Recom2.50 SMA203.32% SMA5022.28% SMA200119.87% Volume713,220 Change-4.41%
May-12-20Downgrade JP Morgan Neutral → Underweight $120 → $158
Mar-26-20Downgrade Barclays Overweight → Equal Weight $90
Oct-23-18Resumed Raymond James Strong Buy $80
Mar-08-18Upgrade Raymond James Outperform → Strong Buy
Jan-22-18Reiterated Barclays Overweight $50 → $60
Jan-04-18Upgrade CL King Neutral → Buy
Sep-19-17Upgrade Piper Jaffray Neutral → Overweight
Jul-18-17Upgrade William Blair Mkt Perform → Outperform
Jul-18-17Upgrade Canaccord Genuity Hold → Buy $25 → $42
Apr-25-17Reiterated Canaccord Genuity Hold $24 → $24.50
Feb-17-17Initiated CL King Neutral
Dec-16-16Downgrade Piper Jaffray Overweight → Neutral
Jun-13-16Upgrade Raymond James Mkt Perform → Outperform
Feb-18-16Reiterated Barclays Overweight $28 → $22
Feb-09-16Downgrade Canaccord Genuity Buy → Hold $22 → $18
Jan-08-16Reiterated Canaccord Genuity Buy $25 → $22
Dec-14-15Downgrade Raymond James Outperform → Mkt Perform
Sep-02-15Initiated Barclays Overweight $28
Jul-31-13Reiterated Canaccord Genuity Buy $30 → $35
Mar-03-11Downgrade Wedbush Outperform → Neutral $14 → $13
Aug-06-20 04:21PM  
10:58AM  
Aug-04-20 09:24AM  
Aug-03-20 11:30AM  
07:12AM  
Aug-02-20 10:51AM  
09:07AM  
Jul-31-20 11:30AM  
11:00AM  
Jul-30-20 08:30PM  
04:10PM  
Jul-29-20 06:00PM  
Jul-24-20 05:45PM  
09:22AM  
Jul-23-20 12:33PM  
Jul-22-20 11:00AM  
05:30AM  
Jul-19-20 07:10AM  
Jul-18-20 08:26PM  
08:44AM  
Jul-17-20 11:00PM  
04:23PM  
06:37AM  
Jul-16-20 05:45PM  
03:04PM  
Jul-13-20 06:10PM  
Jul-10-20 05:45PM  
12:45PM  
Jul-09-20 10:00AM  
Jul-07-20 10:55PM  
08:17AM  
Jul-06-20 05:00PM  
09:41AM  
07:00AM  
Jul-04-20 04:25PM  
Jul-02-20 11:30AM  
Jun-29-20 08:40AM  
08:22AM  
Jun-26-20 12:29PM  
05:47AM  
Jun-24-20 12:07PM  
07:03AM  
Jun-23-20 08:20AM  
07:11AM  
Jun-19-20 01:15AM  
Jun-18-20 12:45PM  
09:26AM  
Jun-16-20 12:03PM  
Jun-15-20 11:30AM  
10:42AM  
07:23AM  
Jun-12-20 06:18PM  
03:45PM  
Jun-11-20 06:49PM  
11:30AM  
Jun-09-20 07:00PM  
Jun-08-20 10:19AM  
06:58AM  
Jun-05-20 10:00AM  
Jun-02-20 12:45PM  
Jun-01-20 02:34PM  
09:50AM  
May-29-20 10:34AM  
08:33AM  
07:50AM  
May-28-20 07:53AM  
May-27-20 11:12AM  
May-26-20 04:10PM  
May-23-20 08:00AM  
May-22-20 12:30PM  
09:45AM  
May-20-20 09:07AM  
08:59AM  
May-19-20 09:42AM  
06:46AM  
May-18-20 08:30PM  
09:43AM  
08:44AM  
May-15-20 03:43PM  
11:48AM  
May-14-20 12:45PM  
May-13-20 11:30AM  
03:19AM  
May-12-20 01:54PM  
01:13PM  
May-11-20 05:40PM  
04:46PM  
04:15PM  
03:24PM  
03:09PM  
01:46PM  
01:05PM  
11:47AM  
10:28AM  
09:59AM  
09:11AM  
08:40AM  
07:38AM  
06:40AM  
May-10-20 12:13PM  
Quidel Corporation develops, manufactures, and markets diagnostic testing solutions for applications in infectious diseases, cardiology, thyroid, women's and general health, eye health, gastrointestinal diseases, and toxicology worldwide. It offers Sofia and Sofia 2 fluorescent immunoassay systems; QuickVue, a lateral flow immunoassay products; and InflammaDry and AdenoPlus, a point-of-care products for the detection of infectious and inflammatory diseases and conditions of the eye. The company also provides Triage MeterPro, a portable testing platform that enables physicians to promote enhanced health outcomes, as well as the detection of certain drugs of abuse; Triage BNP test for use on Beckman Coulter lab analyzers; and Triage TOX drug screen, which provides results for the determination of the presence of drug and/or the major metabolites in urine. In addition, the company offers traditional cell lines, specimen collection devices, media, and controls for use in laboratories that culture and test for various human viruses, including respiratory and herpes family viruses; and cell-based products comprising tubes, shell vials, and multi-well plates. Further, it provides biomarkers, which include clinical and research products for the assessment of osteoporosis and the evaluation of bone resorption/formation; and enzyme linked immunosorbent assays and reagents for the detection of activation products. Additionally, it offers AmpliVue hand-held molecular diagnostic assay platform for the detection of the pathogen; Solana, an amplification and detection system; and Lyra molecular real-time polymerase chain reaction assays. The company markets its products through distributors and direct sales force for use in physician offices, hospitals, clinical laboratories, reference laboratories, leading universities, retail and urgent care clinics, pharmacies, and wellness screening centers. Quidel Corporation was founded in 1979 and is headquartered in San Diego, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BUECHLER KENNETH FDirectorAug 03Option Exercise14.437,800112,55467,624Aug 05 08:26 PM
STEWARD RANDALL JChief Financial OfficerAug 03Option Exercise18.4621,166390,65724,014Aug 05 08:33 PM
Michael Edward L.DirectorAug 03Buy288.123,5001,008,4046,434Aug 05 08:32 PM
STEWARD RANDALL JChief Financial OfficerAug 03Sale286.3121,1666,060,1262,848Aug 05 08:33 PM
Kroll WernerSVP, R&DAug 03Sale287.482,072595,6504,599Aug 05 08:28 PM
BUECHLER KENNETH FDirectorAug 03Sale289.227,8002,255,94659,824Aug 05 08:26 PM
BRYANT DOUGLAS CPresident & CEOJun 11Buy160.335,000801,670445,823Jun 12 05:53 PM
Kroll WernerSVP, R&DMay 27Option Exercise0.004,37608,975May 27 07:54 PM
Kroll WernerSVP, R&DMay 22Option Exercise20.4668,1521,394,42272,751May 27 07:54 PM
Kroll WernerSVP, R&DMay 22Sale174.4468,15211,888,1494,599May 27 07:54 PM
Bujarski Robert JosephSVP, NA Comm Ops & Gen CounselMay 20Sale189.4120,0003,788,28213,383May 22 07:59 PM
Abney Michael Donald Jr.SVP - DistributionMay 18Option Exercise17.9515,970286,67515,432May 20 08:02 PM
BORKAR RATAN SSVP, Intl Comm OperationsMay 18Option Exercise31.8816,332520,69927,171May 20 08:07 PM
STEWARD RANDALL JChief Financial OfficerMay 18Sale185.3520,0003,707,0402,848May 20 08:11 PM
BORKAR RATAN SSVP, Intl Comm OperationsMay 18Sale192.8228,3125,459,113524May 20 08:07 PM
Abney Michael Donald Jr.SVP - DistributionMay 18Sale198.4615,9703,169,3876,634May 20 08:02 PM
SLACIK CHARLES PDirectorMay 15Option Exercise0.00549011,352May 18 08:16 PM
BUECHLER KENNETH FDirectorMay 15Option Exercise0.001,842059,824May 18 08:06 PM
WIDDER KENNETH JDirectorMay 14Option Exercise0.002,100014,416May 18 08:21 PM
Strobeck MatthewDirectorMay 14Option Exercise0.002,10007,399May 18 08:19 PM
BUECHLER KENNETH FDirectorMay 14Option Exercise0.002,100057,982May 18 08:06 PM
SLACIK CHARLES PDirectorMay 14Option Exercise0.002,100010,803May 18 08:16 PM
SCHULER JACK WDirectorMay 14Option Exercise0.002,10003,103,249May 18 08:14 PM
POLAN MARY LAKE PH DDirectorMay 14Option Exercise0.002,100022,884May 18 08:12 PM
ORDONEZ KATHYDirectorMay 14Option Exercise0.001,85601,856May 18 08:10 PM
Michael Edward L.DirectorMay 14Option Exercise0.002,10002,934May 18 08:08 PM
POLAN MARY LAKE PH DDirectorMay 11Sale204.276,7001,368,63020,784May 12 08:01 PM
BUECHLER KENNETH FDirectorMay 11Sale200.005,0001,000,00055,882May 13 08:01 PM
BUECHLER KENNETH FDirectorMay 05Option Exercise13.2510,449138,44960,882May 07 08:05 PM
Russell Edward KeithSVP, Business DevelopmentFeb 26Option Exercise15.4012,601194,05529,791Feb 28 08:03 PM
Russell Edward KeithSVP, Business DevelopmentFeb 26Sale79.5812,6011,002,79617,190Feb 28 08:03 PM
POLAN MARY LAKE PH DDirectorJan 07Option Exercise21.079,041190,49428,584Jan 09 08:23 PM
BORKAR RATAN SSVP, Intl Comm OperationsDec 06Option Exercise15.6711,122174,22620,426Dec 09 07:59 PM
BORKAR RATAN SSVP, Intl Comm OperationsDec 06Sale70.0011,122778,5409,304Dec 09 07:59 PM
BORKAR RATAN SSVP, Intl Comm OperationsDec 05Option Exercise23.414,700110,02714,004Dec 09 07:59 PM
BORKAR RATAN SSVP, Intl Comm OperationsDec 05Sale70.004,700329,0009,304Dec 09 07:59 PM
Kroll WernerSVP, R&DDec 03Option Exercise22.856,620151,26723,389Dec 05 09:35 PM
Kroll WernerSVP, R&DDec 03Sale68.0222,9511,561,0783,795Dec 05 09:35 PM
Russell Edward KeithSVP, Business DevelopmentNov 26Option Exercise19.5615,974312,43832,452Nov 27 07:47 PM
Russell Edward KeithSVP, Business DevelopmentNov 26Sale68.7315,9741,097,95116,478Nov 27 07:47 PM
BORKAR RATAN SSVP, Intl Comm OperationsNov 26Sale68.406,621452,8859,304Nov 27 07:45 PM
BORKAR RATAN SSVP, Intl Comm OperationsNov 25Sale69.1833222,96915,925Nov 27 07:45 PM
BRYANT DOUGLAS CPresident & CEONov 20Option Exercise22.42377,7448,470,451679,186Nov 22 08:03 PM
STEWARD RANDALL JChief Financial OfficerSep 23Option Exercise15.4029,328451,65148,787Sep 25 07:59 PM
STEWARD RANDALL JChief Financial OfficerSep 23Sale62.6029,3281,836,04119,459Sep 25 07:59 PM
GIBSON KARENSVP, IS & Bus. TransformationSep 13Sale67515.004,527305,640,405759Sep 13 08:01 PM
BORKAR RATAN SSVP, Intl Comm OperationsSep 11Option Exercise27.345,575152,42121,768Sep 13 07:58 PM
BUECHLER KENNETH FDirectorSep 11Option Exercise13.254,00053,00054,433Sep 13 07:59 PM
GIBSON KARENSVP, IS & Bus. TransformationSep 11Option Exercise25.5514,354366,74519,545Sep 13 08:01 PM
GIBSON KARENSVP, IS & Bus. TransformationSep 11Sale68.6114,354984,8805,191Sep 13 08:01 PM
BUECHLER KENNETH FDirectorSep 11Sale68.864,000275,42150,433Sep 13 07:59 PM
BORKAR RATAN SSVP, Intl Comm OperationsSep 11Sale70.005,575390,25016,257Sep 13 07:58 PM
Abney Michael Donald Jr.SVP - DistributionSep 10Option Exercise15.408,798135,48914,226Sep 12 08:01 PM
Abney Michael Donald Jr.SVP - DistributionSep 10Sale65.008,798571,8705,790Sep 12 08:01 PM
BRYANT DOUGLAS CPresident & CEOAug 30Option Exercise15.195107,747301,952Aug 30 08:00 PM
BRYANT DOUGLAS CPresident & CEOAug 30Sale65.4051033,354301,442Aug 30 08:00 PM
BRYANT DOUGLAS CPresident & CEOAug 29Option Exercise15.1945,948697,950347,390Aug 30 08:00 PM
BRYANT DOUGLAS CPresident & CEOAug 29Sale64.2845,9482,953,400301,442Aug 30 08:00 PM
BRYANT DOUGLAS CPresident & CEOAug 28Option Exercise15.1925,250383,548326,692Aug 30 08:00 PM
BRYANT DOUGLAS CPresident & CEOAug 28Sale58.3025,2501,472,075301,442Aug 30 08:00 PM